New findings may support the notion that provider-level financial incentives influence decisions to start dialysis at higher levels of kidney function.
Two studies confirm the association, but it remains unclear whether correcting hypomagnesemia will lessen the likelihood of adverse outcomes.
Boiling sliced meat in a pressure cooker filled with soft water may be a promising way for dialysis patients to reduce phosphorus intake.
Training was effective at some time points in decreasing fluid, salt intake among those undergoing hemodialysis.
No matter how much pharmacologic therapy advances, patient behavior will remain a significant factor in the outcomes achieved.
Hemodialysis patients treated with either agent have comparable risks of overall and cardiovascular mortality and cardiovascular events.
In a study, home hemodialysis was associated with a 53% decreased risk of death compared with peritoneal dialysis.
Lowest relative risk of death observed in patients with serum phosphorus and calcium levels of 4.4 mg/dL and 8.8 mg/dL, respectively.
Findings among patients at high risk of acute kidney injury, undergoing cardiac surgery
Ferric pyrophosphate citrate may play a role in the therapeutic armamentarium for dialysis patients.
Patients discharged on Fridays and Saturday are more likely to be readmitted within 30 days than those discharged Sunday through Thursday.
Their risk of a stroke was 46% lower than that of dialysis patients.
Austrian study finds a death rate in winter of 1.60 deaths per 100 patient-months compared with 1.06 deaths per 100 patient-months in summer.
It had a phosphorus-lowering effect similar to that of sevelamer, but had a lower pill burden.
Strategies to overcome motivational barriers may improve mineral bone health.
Lower odds of initiating hemodialysis with artervenous fistula for black and Hispanic versus white patients.
Patients on maintenance hemodialysis have worse physical function than other elderly patients, study says.
We may feel good treating a patient's edema, but is fluid retention always harmful?
Researchers observed significant improvements in inflammation and physical function.
But more detailed genetic studies needed in the dialysis population.
Contrast-Induced Nephropathy is significantly associated with mortality and need for dialysis; hydration is also a predictor of CIN.
Investigators propose a protocol for when patients should be referred to nephrologists.
Recent meta-analysis compared continuous renal replacement therapy and extended daily dialysis.
New report shows that Montenegro had the lowest rate of renal replacement therapy.
Most staff feel that extended treatment time is clinically beneficial, but not all recommend it.
New findings add to a growing body of evidence supporting the avoidance of vitamin K antagonists in dialysis patients.
Emergency department visit and hospitalization rates increased in wake of storm.
Reducing dietary phosphorus is challenging, so researchers have developed a food pyramid for CKD and dialysis patients.
The findings generally support KDOQI guidelines for dialysis patients, which recommend maintaining serum phosphorus levels between 3.5 and 5.5 mg/dL.
- Gleason Score Predicts BCR in High-Risk Prostate Cancer Patients
- Statin Use Fails To Prevent Progression to Lethal Prostate Cancer
- Biomarkers Help Distinguish Prostate Cancer from Prostatitis
- Do Surgeons' Complication Rates Reflect Their Competence?
- Low Magnesium Linked to Worse Survival in Hemodialysis Patients
- Should the U.S. Government Cap the Cost of Cancer Drugs?
- Tamsulosin Improves Passage of Large Ureteric Stones
- Kidney Transplant Outcomes Better If Donors Are Kept in Hypothermia
- Blood Pressure Variability Linked to Heart Disease, Early Death
- Lower Extremity Amputation in Diabetes Linked with Greater Death Risk
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)